Medical Devices France

France Climate-Sensitive Disease Diagnostics Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

France Climate-Sensitive Disease Diagnostics Market Industry Trends and Forecast to 2034: Segmented by (Disease, Test, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

France · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $74.8 Mn Placeholder estimate
Estimate 2025 $79.1 Mn 2.3% of the global market
Projected 2034 $130.3 Mn 64.7% Adds $51.2 Mn over 9 forecast years
CAGR 2025–2034 5.7% Faster than 23% of 173 Medical Devices markets here
Key players 5
  • France is 2.3% of the global market.
  • In Europe, the largest is Germany at $127.2 Mn.
  • Fastest growing: Russia at 6.9% a year.
  • France ranks 3rd of 6 by size in Europe.

Market size projection

France

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$51.2 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Climate-Sensitive Disease Diagnostics Market market size by year, France
YearMarket sizeChange that yearSince 2025
2024 (estimate) $74.8 Mn — —
2025 (base) $79.1 Mn +$4.3 Mn —
2026 (forecast) $83.6 Mn +$4.5 Mn +5.7%
2027 (forecast) $88.4 Mn +$4.8 Mn +11.7%
2028 (forecast) $93.4 Mn +$5.0 Mn +18.1%
2029 (forecast) $98.7 Mn +$5.3 Mn +24.8%
2030 (forecast) $104.4 Mn +$5.6 Mn +31.9%
2031 (forecast) $110.3 Mn +$5.9 Mn +39.5%
2032 (forecast) $116.6 Mn +$6.3 Mn +47.4%
2033 (forecast) $123.2 Mn +$6.6 Mn +55.8%
2034 (forecast) $130.3 Mn +$7.0 Mn +64.7%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

France Climate-Sensitive Disease Diagnostics Market Analysis at a glance
Market size, 2025$79.1 Mn placeholder estimate
Forecast, 2034$130.3 Mn placeholder estimate
Growth (CAGR), 2025–20345.7% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsDisease and test (see all)
Key playersAbbott Laboratories, SD Biosensor, bioMérieux SA, Qiagen N.V., Molbio Diagnostics (see all)
Regulator in FranceANSMSource: ANSM, French medicines agency. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The France Climate-Sensitive Disease Diagnostics Market Analysis Executive Summary

Climate-sensitive disease diagnostics detect illnesses spreading with climate change, such as dengue, malaria, cholera and heat illness.

Key segments of the climate-Sensitive Disease Diagnostics market include disease (Dengue, Malaria and Cholera) and test (Rapid Tests and Molecular Tests).

Bar chart: France Climate-Sensitive Disease Diagnostics market size, 2024–2034, placeholder estimates. $74.8 Mn in 2024, $79.1 Mn in 2025 and $130.3 Mn in 2034, 5.7% CAGR.
France Climate-Sensitive Disease Diagnostics market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

France Climate-Sensitive Disease Diagnostics Market Dynamics

Market Growth Drivers

More heatwaves, air pollution, floods and the spread of climate-sensitive diseases are driving the climate-Sensitive Disease Diagnostics market. Health systems are under pressure to cut their own emissions.

Opportunity

Early warning systems, greener hospitals and climate-resilient supply chains give the climate-Sensitive Disease Diagnostics market strong room to grow.

Market Restraints

Limited dedicated funding, unclear responsibility between agencies and lack of local data hold back the climate-Sensitive Disease Diagnostics market.

Competitive Landscape for Climate-Sensitive Disease Diagnostics Market in France

The climate-Sensitive Disease Diagnostics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Climate-Sensitive Disease Diagnostics Market in France

Climate-Sensitive Disease Diagnostics in France: rules, payment and health figures

Medical devices need CE marking under the EU Medical Device Regulation (MDR); ANSM, the French medicines agency, monitors their safety in France.⁠[1] National health insurance (Assurance Maladie) pays back part of most care costs, and the HAS, the French National Authority for Health, advises on what it should cover.⁠[2] Deaths from air pollution: 10 per 100,000 people in 2019, the latest World Bank figure for France.⁠[3]

[1] ANSM, French medicines agency. Checked 14 Nov 2026.

[2] Assurance Maladie (ameli.fr). Checked 14 Nov 2026.

[3] World Bank Open Data, Deaths from air pollution (per 100,000 people). Retrieved 16 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how climate-Sensitive Disease Diagnostics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in France.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Climate-Sensitive Disease Diagnostics right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 16 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Climate-Sensitive Disease Diagnostics in context

France compared

  • Deaths from air pollution: 10 per 100,000 people (2019). World: 104 per 100,000 people (2019). 6th highest of the 6 countries we cover in Europe.[1]
  • Health spending per person: 5,327 US$ per person (2024). World: 1,317 US$ per person (2023). 3rd highest of the 6 countries we cover in Europe.[2]
  • Doctors: 3.28 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 6th highest of the 6 countries we cover in Europe.[3]

[1] World Bank Open Data, Deaths from air pollution (per 100,000 people). Retrieved 16 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 16 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Climate-Sensitive Disease Diagnostics market in France?
Placeholder estimate: about $79.1 Mn in 2025, rising to about $130.3 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Climate-Sensitive Disease Diagnostics market in France growing?
Placeholder estimate: about 5.7% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Climate-Sensitive Disease Diagnostics market report cover?
The report splits the market by disease (Dengue, Malaria, Cholera, Leptospirosis and more) and test (Rapid Tests, Molecular Tests).
Who are the key players in the Climate-Sensitive Disease Diagnostics market?
Key players include Abbott Laboratories, SD Biosensor, bioMérieux SA, Qiagen N.V. and Molbio Diagnostics.
What is driving the Climate-Sensitive Disease Diagnostics market?
More heatwaves, air pollution, floods and the spread of climate-sensitive diseases are driving the climate-Sensitive Disease Diagnostics market. Health systems are under pressure to cut their own emissions.
Who regulates Climate-Sensitive Disease Diagnostics in France?
Medical devices need CE marking under the EU Medical Device Regulation (MDR); ANSM, the French medicines agency, monitors their safety in France. Source: ANSM, French medicines agency. Checked 14 Nov 2026.
How is healthcare paid for in France?
National health insurance (Assurance Maladie) pays back part of most care costs, and the HAS, the French National Authority for Health, advises on what it should cover. Source: Assurance Maladie (ameli.fr). Checked 14 Nov 2026.
What does World Bank report for France?
Deaths from air pollution: 10 per 100,000 people in 2019, the latest World Bank figure. Source: World Bank Open Data, Deaths from air pollution (per 100,000 people). Retrieved 16 Nov 2026.
How many people in France are 65 or older?
22.5% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 16 Nov 2026.
How much research is published on Climate-Sensitive Disease Diagnostics?
PubMed lists 16 papers on Climate-Sensitive Disease Diagnostics added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in France

See all

Related on climate and health and infectious diseases

See the topic